Slide;Dataset;Tumor;Scanner;Origin;Species
1;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
2;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
3;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
4;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
5;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
6;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
7;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
8;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
9;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
10;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
11;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
12;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
13;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
14;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
15;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
16;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
17;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
18;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
19;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
20;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
21;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
22;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
23;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
24;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
25;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
26;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
27;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
28;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
29;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
30;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
31;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
32;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
33;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
34;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
35;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
36;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
37;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
38;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
39;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
40;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
41;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
42;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
43;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
44;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
45;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
46;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
47;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
48;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
49;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
50;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
51;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
52;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
53;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
54;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
55;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
56;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
57;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
58;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
59;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
60;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
61;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
62;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
63;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
64;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
65;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
66;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
67;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
68;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
69;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
70;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
71;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
72;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
73;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
74;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
75;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
76;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
77;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
78;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
79;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
80;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
81;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
82;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
83;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
84;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
85;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
86;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
87;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
88;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
89;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
90;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
91;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
92;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
93;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
94;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
95;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
96;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
97;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
98;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
99;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
100;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
101;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
102;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
103;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
104;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
105;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
106;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
107;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
108;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
109;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
110;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
111;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
112;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
113;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
114;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
115;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
116;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
117;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
118;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
119;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
120;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
121;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
122;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
123;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
124;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
125;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
126;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
127;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
128;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
129;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
130;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
131;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
132;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
133;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
134;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
135;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
136;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
137;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
138;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
139;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
140;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
141;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
142;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
143;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
144;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
145;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
146;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
147;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
148;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
149;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
150;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
201;train;canine lung cancer;3D Histech;VMU Vienna;Canine
202;train;canine lung cancer;3D Histech;VMU Vienna;Canine
203;test;canine lung cancer;3D Histech;VMU Vienna;Canine
204;train;canine lung cancer;3D Histech;VMU Vienna;Canine
205;train;canine lung cancer;3D Histech;VMU Vienna;Canine
206;train;canine lung cancer;3D Histech;VMU Vienna;Canine
207;train;canine lung cancer;3D Histech;VMU Vienna;Canine
208;train;canine lung cancer;3D Histech;VMU Vienna;Canine
209;train;canine lung cancer;3D Histech;VMU Vienna;Canine
210;train;canine lung cancer;3D Histech;VMU Vienna;Canine
211;train;canine lung cancer;3D Histech;VMU Vienna;Canine
212;test;canine lung cancer;3D Histech;VMU Vienna;Canine
213;train;canine lung cancer;3D Histech;VMU Vienna;Canine
214;train;canine lung cancer;3D Histech;VMU Vienna;Canine
215;train;canine lung cancer;3D Histech;VMU Vienna;Canine
216;train;canine lung cancer;3D Histech;VMU Vienna;Canine
217;train;canine lung cancer;3D Histech;VMU Vienna;Canine
218;test;canine lung cancer;3D Histech;VMU Vienna;Canine
219;train;canine lung cancer;3D Histech;VMU Vienna;Canine
220;test;canine lung cancer;3D Histech;VMU Vienna;Canine
221;train;canine lung cancer;3D Histech;VMU Vienna;Canine
222;train;canine lung cancer;3D Histech;VMU Vienna;Canine
223;train;canine lung cancer;3D Histech;VMU Vienna;Canine
224;train;canine lung cancer;3D Histech;VMU Vienna;Canine
225;train;canine lung cancer;3D Histech;VMU Vienna;Canine
226;train;canine lung cancer;3D Histech;VMU Vienna;Canine
227;train;canine lung cancer;3D Histech;VMU Vienna;Canine
228;train;canine lung cancer;3D Histech;VMU Vienna;Canine
229;train;canine lung cancer;3D Histech;VMU Vienna;Canine
230;test;canine lung cancer;3D Histech;VMU Vienna;Canine
231;train;canine lung cancer;3D Histech;VMU Vienna;Canine
232;test;canine lung cancer;3D Histech;VMU Vienna;Canine
233;train;canine lung cancer;3D Histech;VMU Vienna;Canine
234;test;canine lung cancer;3D Histech;VMU Vienna;Canine
235;train;canine lung cancer;3D Histech;VMU Vienna;Canine
236;test;canine lung cancer;3D Histech;VMU Vienna;Canine
237;train;canine lung cancer;3D Histech;VMU Vienna;Canine
238;train;canine lung cancer;3D Histech;VMU Vienna;Canine
239;test;canine lung cancer;3D Histech;VMU Vienna;Canine
240;train;canine lung cancer;3D Histech;VMU Vienna;Canine
241;test;canine lung cancer;3D Histech;VMU Vienna;Canine
242;train;canine lung cancer;3D Histech;VMU Vienna;Canine
243;train;canine lung cancer;3D Histech;VMU Vienna;Canine
244;train;canine lung cancer;3D Histech;VMU Vienna;Canine
245;train;canine lymphoma;3D Histech;VMU Vienna;Canine
246;train;canine lymphoma;3D Histech;VMU Vienna;Canine
247;train;canine lymphoma;3D Histech;VMU Vienna;Canine
248;train;canine lymphoma;3D Histech;VMU Vienna;Canine
249;test;canine lymphoma;3D Histech;VMU Vienna;Canine
250;train;canine lymphoma;3D Histech;VMU Vienna;Canine
251;test;canine lymphoma;3D Histech;VMU Vienna;Canine
252;test;canine lymphoma;3D Histech;VMU Vienna;Canine
253;test;canine lymphoma;3D Histech;VMU Vienna;Canine
254;train;canine lymphoma;3D Histech;VMU Vienna;Canine
255;train;canine lymphoma;3D Histech;VMU Vienna;Canine
256;test;canine lymphoma;3D Histech;VMU Vienna;Canine
257;test;canine lymphoma;3D Histech;VMU Vienna;Canine
258;train;canine lymphoma;3D Histech;VMU Vienna;Canine
259;train;canine lymphoma;3D Histech;VMU Vienna;Canine
260;train;canine lymphoma;3D Histech;VMU Vienna;Canine
261;train;canine lymphoma;3D Histech;VMU Vienna;Canine
262;train;canine lymphoma;3D Histech;VMU Vienna;Canine
263;train;canine lymphoma;3D Histech;VMU Vienna;Canine
264;train;canine lymphoma;3D Histech;VMU Vienna;Canine
265;train;canine lymphoma;3D Histech;VMU Vienna;Canine
266;train;canine lymphoma;3D Histech;VMU Vienna;Canine
267;train;canine lymphoma;3D Histech;VMU Vienna;Canine
268;test;canine lymphoma;3D Histech;VMU Vienna;Canine
269;test;canine lymphoma;3D Histech;VMU Vienna;Canine
270;train;canine lymphoma;3D Histech;VMU Vienna;Canine
271;train;canine lymphoma;3D Histech;VMU Vienna;Canine
272;train;canine lymphoma;3D Histech;VMU Vienna;Canine
273;train;canine lymphoma;3D Histech;VMU Vienna;Canine
274;train;canine lymphoma;3D Histech;VMU Vienna;Canine
275;train;canine lymphoma;3D Histech;VMU Vienna;Canine
276;test;canine lymphoma;3D Histech;VMU Vienna;Canine
277;train;canine lymphoma;3D Histech;VMU Vienna;Canine
278;train;canine lymphoma;3D Histech;VMU Vienna;Canine
279;train;canine lymphoma;3D Histech;VMU Vienna;Canine
280;train;canine lymphoma;3D Histech;VMU Vienna;Canine
281;train;canine lymphoma;3D Histech;VMU Vienna;Canine
282;train;canine lymphoma;3D Histech;VMU Vienna;Canine
283;train;canine lymphoma;3D Histech;VMU Vienna;Canine
284;train;canine lymphoma;3D Histech;VMU Vienna;Canine
285;train;canine lymphoma;3D Histech;VMU Vienna;Canine
286;train;canine lymphoma;3D Histech;VMU Vienna;Canine
287;train;canine lymphoma;3D Histech;VMU Vienna;Canine
288;train;canine lymphoma;3D Histech;VMU Vienna;Canine
289;train;canine lymphoma;3D Histech;VMU Vienna;Canine
290;train;canine lymphoma;3D Histech;VMU Vienna;Canine
291;test;canine lymphoma;3D Histech;VMU Vienna;Canine
292;test;canine lymphoma;3D Histech;VMU Vienna;Canine
293;train;canine lymphoma;3D Histech;VMU Vienna;Canine
294;train;canine lymphoma;3D Histech;VMU Vienna;Canine
295;test;canine lymphoma;3D Histech;VMU Vienna;Canine
296;train;canine lymphoma;3D Histech;VMU Vienna;Canine
297;train;canine lymphoma;3D Histech;VMU Vienna;Canine
298;train;canine lymphoma;3D Histech;VMU Vienna;Canine
299;train;canine lymphoma;3D Histech;VMU Vienna;Canine
300;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
301;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
302;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
303;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
304;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
305;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
306;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
307;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
308;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
309;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
310;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
311;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
312;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
313;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
314;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
315;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
316;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
317;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
318;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
319;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
320;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
321;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
322;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
323;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
324;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
325;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
326;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
327;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
328;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
329;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
330;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
331;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
332;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
333;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
334;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
335;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
336;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
337;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
338;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
339;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
340;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
341;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
342;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
343;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
344;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
345;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
346;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
347;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
348;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
349;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
350;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
351;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
352;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
353;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
354;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
355;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
356;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
357;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
358;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
359;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
360;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
361;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
362;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
363;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
364;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
365;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
366;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
367;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
368;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
369;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
370;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
371;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
372;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
373;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
374;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
375;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
376;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
377;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
378;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
379;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
380;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
381;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
382;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
383;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
384;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
385;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
386;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
387;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
388;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
389;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
390;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
391;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
392;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
393;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
394;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
395;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
396;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
397;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
398;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
399;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
400;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
401;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
402;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
403;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
404;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
405;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
406;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
407;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
408;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
409;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
410;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
411;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
412;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
413;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
414;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
415;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
416;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
417;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
418;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
419;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
420;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
421;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
422;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
423;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
424;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
425;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
426;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
427;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
428;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
429;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
430;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
431;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
432;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
433;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
434;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
435;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
436;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
437;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
438;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
439;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
440;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
441;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
442;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
443;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
444;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
445;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
446;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
447;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
448;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
449;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
450;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
451;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
452;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
453;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
454;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
455;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
456;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
457;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
458;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
459;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
460;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
461;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
462;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
463;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
464;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
465;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
466;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
467;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
468;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
469;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
470;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
471;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
472;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
473;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
474;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
475;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
476;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
477;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
478;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
479;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
480;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
481;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
482;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
483;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
484;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
485;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
486;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
487;test;canine soft tissue sarcoma;3D Histech;AMC New York;Human
488;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
489;train;canine soft tissue sarcoma;3D Histech;AMC New York;Human
490;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
491;test;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
492;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
493;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
494;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
495;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
496;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
497;test;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
498;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
499;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
500;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
501;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
502;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
503;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
504;test;canine soft tissue sarcoma;3D Histech;VMU Vienna;Human
505;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
506;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
507;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
508;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
509;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
510;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
511;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
512;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
513;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
514;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
515;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
516;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
517;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
518;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
519;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
520;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
521;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
522;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
523;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
524;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
525;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
526;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
527;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
528;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
529;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
530;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
531;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
532;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
533;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
534;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
535;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
536;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
537;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
538;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
539;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
540;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
541;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
542;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
543;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
544;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
545;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
546;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
547;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
548;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
549;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
550;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
551;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
552;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
553;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
